Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

IMODE-CKD

Financiado

Cerrado

Clinical and system omics for the identification of the MOlecular DEterminants...

Clinical and system omics for the identification of the MOlecular DEterminants of established Chronic Kidney Disease iMODE-CKD integrates multi-disciplinary expertise in proteomics, metabolomics, transcriptomics, bioinformatics, pathology, and clinical science from leading academic and industrial investigators, establishing a unique training pla... ver más

31/08/2017

BIOMEDICAL RESEARC...

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHI... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 11 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2017-08-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

11 Participantes

BIOMEDICAL RESEARCH FOUNDATI...

0.00€ | Lider

Ss. CYRIL AND METHODIUS UNIV...

N.D. | Participante

UNIMIB

N.D. | Participante

UNIVERSITY OF GLASGOW

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

CaReSyAn Combatting the CardioRenal Syndrome towards an integrative... 3M€ Cerrado

PROCEED Proteomics for Chronic Kidney Disease Therapy 171K€ Cerrado

PROTOCLIN IMPROVEMENT OF TOOLS AND PORTABILITY OF MASS SPECTROMETRY BA... 609K€ Cerrado

BEAt-DKD Biomarker Enterprise to Attack DKD Sofia ref. 115974 31M€ Cerrado

SYSKID Systems biology towards novel chronic kidney disease diagnos... 16M€ Cerrado

DECODE-DKD Decoding diabetic kidney disease 2M€ Cerrado

Líder del proyecto

IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHI... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto iMODE-CKD integrates multi-disciplinary expertise in proteomics, metabolomics, transcriptomics, bioinformatics, pathology, and clinical science from leading academic and industrial investigators, establishing a unique training platform on biomarker research and Systems Biology. Special emphasis is placed on the application of a wide range of –omics and bioinformatics techniques to clinical research. This educational scope is placed in the context of a significant research objective: to improve quality of life of patients with chronic kidney disease (CKD) and diminish the severe health and economic burden imposed by this disease, by providing better diagnostic and prognostic means. Established CKD has been selected based on the accumulation of existing molecular data, and complementarity to active European programs focusing on early stage CKD in the context of diabetes and hypertension, in which participants of the consortium are actively involved. The main objectives of iMODE-CKD are: - Training young scientists to become the next generation of true translational multidisciplinary researchers exploiting multiple -omics technologies to their full extent. - Training young scientists in Systems Biology approaches to decipher molecular pathology and understanding clinical phenotypes. - Identifying and validating molecules involved in progression of renal complications trough clinical –omics in established CKD. - Understanding the molecular determinants of established CKD through integrative Systems Biology. iMODE-CKD provides the opportunity to train young researchers not only in the different fields of -omics research, but also in -omics data evaluation, combining of datasets from different -omics traits, and exploiting both, data and literature, to enable the generation of in silico models of the molecular pathology of specific diseases. Such approaches will also enable development of new and specific drugs; and pave the road towards stratified/personalized medicine.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores